SlideShare a Scribd company logo
Lecture1 Preformulation (1).pptx uuuuuuu
Aim of the course
After Completing this course, the
student will be able to:
1- Know various considerations in
development of pharmaceutical
dosage forms.
2- Design the dosage form based on
Pre-formulation parameters.
3- Understand the concept and
objective of controlled release.
4- Explain various physicochemical
characteristics of drug substances
and their importance in
formulation of dosage form
Students evaluation
Assessment methods
Midterm exam
20 marks
Quiz I : 20/10/2024 10 marks
Quiz 2 : 10/11/2024 10 marks
Assignment
10 marks
• Reports about preformulation studies for different marketed
drug.
• A report for each student individually
• Deadline for submitting reports 1/11/2024
Practical exam
30 marks
Practical exam 1 10/11/2024 15 marks
Practical exam 2 29/12/2024 15 marks
Oral exam 15 marks
Final Written 75 marks
Lecture1 Preformulation (1).pptx uuuuuuu
Week Theoretical Topics Practical Topics Lecturer
1 Preformulation studies Flowability evaluation
Ass. Prof /
Mahmoud omr
Ass. Prof /
Omaya Ali
2 Solubility Solubility determination
3 Dissolution Determination of dissolution rate
4 Partition coefficient
Determination of partition
coefficient
5 Melting point Particle size determination
6 Stability Stability
7 Controlled release Practical exam I
8 Matrix tablets Determination of drug release
9 Osmotic pump Kinetics
10 Matrix tablets Preparation of microspheres
11 Microcapsules Rate and order of reaction
12 Nanotechnology Transdermal patches
13 Transdermal patches Transdermal patches
14 Practical exam II
• After completing this
lecture, the students ...
1. Know the concept of
Preformulation.
2. Understand different factors
considered in preformulation.
3. Differentiate between flowability
and compressibility.
4. Understand each step of
preformulation.
5. Realize the properties to be studied
in preformulation.
• Preformulation testing is the first step in
the development of dosage forms of a
drug substance.
• It can be defined as an investigation of
physical and chemical properties of a
drug substance alone and when
combined with excipients.
• The overall objective of Preformulation
testing is to generate information useful
to the formulator in developing stable
and bioavailable dosage forms.
Goals of Preformulation
• To formulate an elegant, safe,
efficacious dosage form with good
bioavailability.
• To formulate new dosage form of
already existing drug.
• Determination of all the properties of
drug and the best suitable dosage
form for the drug.
Pharmaceutical factors affecting
preformulation studies
Lecture1 Preformulation (1).pptx uuuuuuu
1. Flow properties
• Flow properties is an importance when
handling a drug powder.
• Sufficient flow is required for uniformity of
dosage form, so it is necessary to determine the
flow of material in preformulation stage.
• Extreme increase in flow may improve weight
uniformity but may reduce content uniformity
through increased segregation.
Flowability evaluation
By angle of repose
Lecture1 Preformulation (1).pptx uuuuuuu
• A static heap of powder with only gravity
acting upon it will tend to a form a conical
shape.
• There is an empirical relationship
between θ and the ability of the powder
to flow.
Lecture1 Preformulation (1).pptx uuuuuuu
Relationship between angle of repose
and Carr's index
2. Density
• The density of a substance is the relationship between
the mass of the substance and how much space it takes
up (volume).
• The mass of atoms, their size, and how they are
arranged determine the density of a substance.
• Density equals the mass of the substance divided by its
volume.
D = m/v
• For the measurement of density of materials. Such
techniques can be used:
1. Hydrometer (a buoyancy method for liquids).
2. Hydrostatic balance (a buoyancy method for
liquids and solids).
3. Compressibility
• Compressibility is the ability of powder to
decrease in volume under pressure.
% compressibility =Tapped -Bulk density/Tapped density× 100
4. Hygroscopicity
• Hygroscopicity: is the tendency of material to
absorb moisture from atmosphere.
• Deliquescent: is the hygroscopic substance
which absorb moisture from air and they can be
liquefied partially or wholly forming solution.
• Efflorescent: a substance which loses water to
form lower hydrate or become anhydrous.
Lecture1 Preformulation (1).pptx uuuuuuu
5. Electrostatic charge
• Electrostatic charges are the consequence of classic
attraction & repulsion effect between charges.
• Electrostatic charge is produced by:
1. Mechanical impact
2. Friction between two surfaces
3. Rupturing of particles
Method of determination:
1. ELP (Electrical lower pressure impactor) give detailed
charge profile of aerosole particles
2. Electrostatic tester: which consists of electrostatic
voltage sensing probs.
Lecture1 Preformulation (1).pptx uuuuuuu
Determination of viscosity
1. Capillary viscometer
2. Falling sphere viscometer
3. Cup and bob viscometer
4. Cora and plate viscometer
5. Broke feiled viscometer
7. Wettability
• Wettability of a solid is an important property with
regards of formulation of solid dosage form.
• Adsorption at solid surface is involved in wetting.
• It may influence granulation of solid, penetration of
dissolution fluid into tablet and granules and
adhesion of coating material into tablets.
• Wettability is determined by contact angel.
• The contact angel is the angel between a liquid
droplet and the surface over which it spreads.
Properties to be studied in
Preformulation
1. Organoleptic Properties
2. Purity
3. Particle Size, Shape, and Surface Area
4. Solubility
5. Dissolution
6. Absorption
7. Stability testing
8. Melting point
9. Polymorphism
10.Pseudopolymorphism
11.Assay development
12. Excipient compatibility
1. Organoleptic Properties
• Include taste, sight, smell, and touch.
• Modern medicines require that pharmaceutical
dosage forms are acceptable to the patient.
• Unfortunately, many drug substances in use
today are unpalatable and unattractive in their
natural state and dosage forms containing such
drugs particularly oral preparations, may
require the addition of approved flavours
and/or colours.
• The use of flavours applies primarily to liquid
dosage forms intended for oral administration.
• Flavours are usually composed of mixtures of
Terminology to describe organoleptic
properties
2. Purity
• Impurity can affect:
- Stability: metal contamination in ppm
- Appearance: off-color
-Toxic impurities : aromatic amine
• often remedial action is simple: re-
crystallization
Techniques used for characterizing purity
• Thin layer chromatography (TLC)
• High-performance liquid chromatography (HPLC)
• Gas chromatography (GC)
• Differential scanning calorimetry (DSC)
Differential scanning calorimetry (DSC)
• DSC can be used for purity analysis
However, this is restricted to those
compounds that are greater than 98%
pure.
• It may be appropriate, if HPLC methods
are not available, to use DSC to estimate
purity, but it should be emphasized that
DSC is much less accurate than HPLC in
this respect.
Lecture1 Preformulation (1).pptx uuuuuuu
3. Particle Size, Shape, and Surface Area
• Effects of particle size distribution and
shape on:
- Chemical and physical properties of drug.
- Bioavailability of drug substances.
- Flow and mixing efficiency of powders.
-Stability, fine materials relatively more
open to attack from atmospheric O2,
heat, light, humidity, and interacting
excipients than coarse materials.
Drawbacks of grinding
• material losses
• static charge build-up
• aggregation leading to increase hydrophobicity
• polymorphic or chemical transformations
Determination of Surface Area
Brunauer-Emmett-Teller(BET)
• Called theory of adsorption.
• Most substances will adsorb a monomolecular layer of a
gas under certain conditions of partial pressure (of the gas)
and temperature.
• Knowing the monolayer capacity of an adsorbent (i.e., the
quantity of adsorbate that can be accommodated as a
monolayer on the surface of a solid, the adsorbent) and the
area of the adsorbate molecule, the surface area can, in
principle be calculated.
• Most commonly, nitrogen is used as the adsorbate at a
specific partial pressure established by mixing it with an
inert gas, typically helium.
• The adsorption process is carried out at liquid nitrogen
temperature (-195o
C).
Brunauer-Emmett-Teller (BET)
adsorption isotherm
1 = C - 1 P
+
λ[ )Po/P ) -1] λmC Po
1
λmC
λ = g of adsorbate per g of adsorbent
λm = maximum value of that λ ratio for a monolayer
P = partial pressure of the adsorbate gas
Po = vapor pressure of the pure adsorbate gas
C = constant
P, Po, and C are temperature-dependent
• The values of λ (g of adsorbate/g of adsorbent) at
various P values (partial pressure of the adsorbate gas)
could be obtained from the experiment through
instrument.
• Po ) vapor pressure of the pure adsorbate gas) can be
obtained from the literature.
• Plotting the term against P/Po will
obtain a straight line with
• slope = (C - 1)/ λmC
• intercept = 1/ λmC
•The term C and λm can readily be obtained.
1
λ[ )Po/P ) -1]
Particle Diameter and Surface Area

More Related Content

PDF
Industrial Pharmacy Notes for M.Pharmacy
PPTX
P tech Chap 1 pharma technology. pptx
PPTX
Preformulation Studies of Herbal Cosmetics
PPT
Pre-Formulation [Autosaved] [Autosaved] [Autosaved].ppt
PDF
Pre-Formulation.pdf
PPTX
UNIT 1 - PREFORMULATION.pptx
PPTX
preformulation.pptx
PPTX
Pharmaceutical Technology 1
Industrial Pharmacy Notes for M.Pharmacy
P tech Chap 1 pharma technology. pptx
Preformulation Studies of Herbal Cosmetics
Pre-Formulation [Autosaved] [Autosaved] [Autosaved].ppt
Pre-Formulation.pdf
UNIT 1 - PREFORMULATION.pptx
preformulation.pptx
Pharmaceutical Technology 1

Similar to Lecture1 Preformulation (1).pptx uuuuuuu (20)

PPTX
Unit-1 Preformulation.pptx
PPT
Preformulation testing of solid dosage forms
PPTX
Preformation supriya
PPTX
Preformulation Studies
PPTX
Preformulation/pharmaceutical preformulation
PPTX
Preformulation.
PPTX
B.Pharm - IP-I Unit I - Preformulation.pptxB
PDF
Preformulation unit i uips (2)
PPTX
pref.pptx
PPTX
PREFORMULATION STUDIES OF DRUGS PRESENTED BY MANSI SANGRI
PPTX
Pre formulation protocol
PPTX
preformulation study ralated to pharmaceuticals
PPT
1. preformulation
PPTX
preformulation(Ver 3.0).pptx
PPTX
Preformulation and physicochemical property of the drug
PPTX
Lecture 1.pptx
PPTX
Industrial pharmacy.pptx
PPTX
PPTX
PREFORMULATION.pptx
Unit-1 Preformulation.pptx
Preformulation testing of solid dosage forms
Preformation supriya
Preformulation Studies
Preformulation/pharmaceutical preformulation
Preformulation.
B.Pharm - IP-I Unit I - Preformulation.pptxB
Preformulation unit i uips (2)
pref.pptx
PREFORMULATION STUDIES OF DRUGS PRESENTED BY MANSI SANGRI
Pre formulation protocol
preformulation study ralated to pharmaceuticals
1. preformulation
preformulation(Ver 3.0).pptx
Preformulation and physicochemical property of the drug
Lecture 1.pptx
Industrial pharmacy.pptx
PREFORMULATION.pptx
Ad

Recently uploaded (20)

PDF
CAPERS-LRD-z9:AGas-enshroudedLittleRedDotHostingaBroad-lineActive GalacticNuc...
PPTX
Microbiology with diagram medical studies .pptx
PDF
Biophysics 2.pdffffffffffffffffffffffffff
PPTX
EPIDURAL ANESTHESIA ANATOMY AND PHYSIOLOGY.pptx
PPTX
7. General Toxicologyfor clinical phrmacy.pptx
PPTX
microscope-Lecturecjchchchchcuvuvhc.pptx
PPTX
Taita Taveta Laboratory Technician Workshop Presentation.pptx
PPT
protein biochemistry.ppt for university classes
PPTX
G5Q1W8 PPT SCIENCE.pptx 2025-2026 GRADE 5
PDF
AlphaEarth Foundations and the Satellite Embedding dataset
PDF
. Radiology Case Scenariosssssssssssssss
PPTX
Cell Membrane: Structure, Composition & Functions
PDF
Sciences of Europe No 170 (2025)
DOCX
Viruses (History, structure and composition, classification, Bacteriophage Re...
PDF
Placing the Near-Earth Object Impact Probability in Context
PPTX
ECG_Course_Presentation د.محمد صقران ppt
PPTX
ognitive-behavioral therapy, mindfulness-based approaches, coping skills trai...
PPTX
BIOMOLECULES PPT........................
PPTX
Protein & Amino Acid Structures Levels of protein structure (primary, seconda...
PPTX
The KM-GBF monitoring framework – status & key messages.pptx
CAPERS-LRD-z9:AGas-enshroudedLittleRedDotHostingaBroad-lineActive GalacticNuc...
Microbiology with diagram medical studies .pptx
Biophysics 2.pdffffffffffffffffffffffffff
EPIDURAL ANESTHESIA ANATOMY AND PHYSIOLOGY.pptx
7. General Toxicologyfor clinical phrmacy.pptx
microscope-Lecturecjchchchchcuvuvhc.pptx
Taita Taveta Laboratory Technician Workshop Presentation.pptx
protein biochemistry.ppt for university classes
G5Q1W8 PPT SCIENCE.pptx 2025-2026 GRADE 5
AlphaEarth Foundations and the Satellite Embedding dataset
. Radiology Case Scenariosssssssssssssss
Cell Membrane: Structure, Composition & Functions
Sciences of Europe No 170 (2025)
Viruses (History, structure and composition, classification, Bacteriophage Re...
Placing the Near-Earth Object Impact Probability in Context
ECG_Course_Presentation د.محمد صقران ppt
ognitive-behavioral therapy, mindfulness-based approaches, coping skills trai...
BIOMOLECULES PPT........................
Protein & Amino Acid Structures Levels of protein structure (primary, seconda...
The KM-GBF monitoring framework – status & key messages.pptx
Ad

Lecture1 Preformulation (1).pptx uuuuuuu

  • 2. Aim of the course After Completing this course, the student will be able to: 1- Know various considerations in development of pharmaceutical dosage forms. 2- Design the dosage form based on Pre-formulation parameters. 3- Understand the concept and objective of controlled release. 4- Explain various physicochemical characteristics of drug substances and their importance in formulation of dosage form
  • 4. Assessment methods Midterm exam 20 marks Quiz I : 20/10/2024 10 marks Quiz 2 : 10/11/2024 10 marks Assignment 10 marks • Reports about preformulation studies for different marketed drug. • A report for each student individually • Deadline for submitting reports 1/11/2024 Practical exam 30 marks Practical exam 1 10/11/2024 15 marks Practical exam 2 29/12/2024 15 marks Oral exam 15 marks Final Written 75 marks
  • 6. Week Theoretical Topics Practical Topics Lecturer 1 Preformulation studies Flowability evaluation Ass. Prof / Mahmoud omr Ass. Prof / Omaya Ali 2 Solubility Solubility determination 3 Dissolution Determination of dissolution rate 4 Partition coefficient Determination of partition coefficient 5 Melting point Particle size determination 6 Stability Stability 7 Controlled release Practical exam I 8 Matrix tablets Determination of drug release 9 Osmotic pump Kinetics 10 Matrix tablets Preparation of microspheres 11 Microcapsules Rate and order of reaction 12 Nanotechnology Transdermal patches 13 Transdermal patches Transdermal patches 14 Practical exam II
  • 7. • After completing this lecture, the students ... 1. Know the concept of Preformulation. 2. Understand different factors considered in preformulation. 3. Differentiate between flowability and compressibility. 4. Understand each step of preformulation. 5. Realize the properties to be studied in preformulation.
  • 8. • Preformulation testing is the first step in the development of dosage forms of a drug substance. • It can be defined as an investigation of physical and chemical properties of a drug substance alone and when combined with excipients. • The overall objective of Preformulation testing is to generate information useful to the formulator in developing stable and bioavailable dosage forms.
  • 10. • To formulate an elegant, safe, efficacious dosage form with good bioavailability. • To formulate new dosage form of already existing drug. • Determination of all the properties of drug and the best suitable dosage form for the drug.
  • 14. • Flow properties is an importance when handling a drug powder. • Sufficient flow is required for uniformity of dosage form, so it is necessary to determine the flow of material in preformulation stage. • Extreme increase in flow may improve weight uniformity but may reduce content uniformity through increased segregation.
  • 17. • A static heap of powder with only gravity acting upon it will tend to a form a conical shape. • There is an empirical relationship between θ and the ability of the powder to flow.
  • 19. Relationship between angle of repose and Carr's index
  • 21. • The density of a substance is the relationship between the mass of the substance and how much space it takes up (volume). • The mass of atoms, their size, and how they are arranged determine the density of a substance. • Density equals the mass of the substance divided by its volume. D = m/v • For the measurement of density of materials. Such techniques can be used: 1. Hydrometer (a buoyancy method for liquids). 2. Hydrostatic balance (a buoyancy method for liquids and solids).
  • 23. • Compressibility is the ability of powder to decrease in volume under pressure. % compressibility =Tapped -Bulk density/Tapped density× 100
  • 24. 4. Hygroscopicity • Hygroscopicity: is the tendency of material to absorb moisture from atmosphere. • Deliquescent: is the hygroscopic substance which absorb moisture from air and they can be liquefied partially or wholly forming solution. • Efflorescent: a substance which loses water to form lower hydrate or become anhydrous.
  • 27. • Electrostatic charges are the consequence of classic attraction & repulsion effect between charges. • Electrostatic charge is produced by: 1. Mechanical impact 2. Friction between two surfaces 3. Rupturing of particles Method of determination: 1. ELP (Electrical lower pressure impactor) give detailed charge profile of aerosole particles 2. Electrostatic tester: which consists of electrostatic voltage sensing probs.
  • 29. Determination of viscosity 1. Capillary viscometer 2. Falling sphere viscometer 3. Cup and bob viscometer 4. Cora and plate viscometer 5. Broke feiled viscometer
  • 31. • Wettability of a solid is an important property with regards of formulation of solid dosage form. • Adsorption at solid surface is involved in wetting. • It may influence granulation of solid, penetration of dissolution fluid into tablet and granules and adhesion of coating material into tablets. • Wettability is determined by contact angel. • The contact angel is the angel between a liquid droplet and the surface over which it spreads.
  • 32. Properties to be studied in Preformulation
  • 33. 1. Organoleptic Properties 2. Purity 3. Particle Size, Shape, and Surface Area 4. Solubility 5. Dissolution 6. Absorption 7. Stability testing 8. Melting point 9. Polymorphism 10.Pseudopolymorphism 11.Assay development 12. Excipient compatibility
  • 35. • Include taste, sight, smell, and touch. • Modern medicines require that pharmaceutical dosage forms are acceptable to the patient. • Unfortunately, many drug substances in use today are unpalatable and unattractive in their natural state and dosage forms containing such drugs particularly oral preparations, may require the addition of approved flavours and/or colours. • The use of flavours applies primarily to liquid dosage forms intended for oral administration. • Flavours are usually composed of mixtures of
  • 36. Terminology to describe organoleptic properties
  • 38. • Impurity can affect: - Stability: metal contamination in ppm - Appearance: off-color -Toxic impurities : aromatic amine • often remedial action is simple: re- crystallization
  • 39. Techniques used for characterizing purity
  • 40. • Thin layer chromatography (TLC) • High-performance liquid chromatography (HPLC) • Gas chromatography (GC) • Differential scanning calorimetry (DSC)
  • 42. • DSC can be used for purity analysis However, this is restricted to those compounds that are greater than 98% pure. • It may be appropriate, if HPLC methods are not available, to use DSC to estimate purity, but it should be emphasized that DSC is much less accurate than HPLC in this respect.
  • 44. 3. Particle Size, Shape, and Surface Area
  • 45. • Effects of particle size distribution and shape on: - Chemical and physical properties of drug. - Bioavailability of drug substances. - Flow and mixing efficiency of powders. -Stability, fine materials relatively more open to attack from atmospheric O2, heat, light, humidity, and interacting excipients than coarse materials.
  • 47. • material losses • static charge build-up • aggregation leading to increase hydrophobicity • polymorphic or chemical transformations
  • 49. Brunauer-Emmett-Teller(BET) • Called theory of adsorption. • Most substances will adsorb a monomolecular layer of a gas under certain conditions of partial pressure (of the gas) and temperature. • Knowing the monolayer capacity of an adsorbent (i.e., the quantity of adsorbate that can be accommodated as a monolayer on the surface of a solid, the adsorbent) and the area of the adsorbate molecule, the surface area can, in principle be calculated. • Most commonly, nitrogen is used as the adsorbate at a specific partial pressure established by mixing it with an inert gas, typically helium. • The adsorption process is carried out at liquid nitrogen temperature (-195o C).
  • 50. Brunauer-Emmett-Teller (BET) adsorption isotherm 1 = C - 1 P + λ[ )Po/P ) -1] λmC Po 1 λmC λ = g of adsorbate per g of adsorbent λm = maximum value of that λ ratio for a monolayer P = partial pressure of the adsorbate gas Po = vapor pressure of the pure adsorbate gas C = constant P, Po, and C are temperature-dependent
  • 51. • The values of λ (g of adsorbate/g of adsorbent) at various P values (partial pressure of the adsorbate gas) could be obtained from the experiment through instrument. • Po ) vapor pressure of the pure adsorbate gas) can be obtained from the literature. • Plotting the term against P/Po will obtain a straight line with • slope = (C - 1)/ λmC • intercept = 1/ λmC •The term C and λm can readily be obtained. 1 λ[ )Po/P ) -1]
  • 52. Particle Diameter and Surface Area

Editor's Notes

  • #8: - Clearance may also be considered as the fraction of drug removed per unit time multiplied by the VD.